Brief: Piramal Pharma Says Successful Closure Of US FDA Inspection At Co Manufacturing Facility Located At Sellersville, USA
18/04/2023 14:55
April 18 (Reuters) - Piramal Pharma Ltd PIRM.NS :
* SUCCESSFUL CLOSURE OF US FDA INSPECTION AT CO
MANUFACTURING
FACILITY LOCATED AT SELLERSVILLE, USA
* US FDA HAS ISSUED AN ESTABLISHMENT INSPECTION REPORT FOR
THE
SAID MANUFACTURING FACILITY
Source text for Eikon: ID:nNSE5dNTWf
Further company coverage: PIRM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma Receives Permanent Revocation Of Closure Order For Dahej Site
Brief: Piramal Pharma Solutions Announces Partnership With Botanix To Support Drug Substance Development
Brief: Piramal Pharma Announces Successful Closure Of Us FDA Inspection At Digwal Facility
India's Piramal Pharma eyes complex drug demand for earnings boost, chair says
Brief: Piramal Pharma Says Closure Of US FDA Inspection At Manufacturing Facility At Lexington